Clinical Outcome Assessments in Pediatric Patients With Ulcerative Colitis and Crohn's Disease Receiving Biologics: A Retrospective Cohort Study.

Theresa Hunter GibbleWendy J KomocsarChunyan LiuRichard B CollettiSteven J SteinerJennifer L DotsonKeith BenkovNanhua ZhangWallace Crandall

Published in: Crohn's & colitis 360 (2022)

Disease activity scores improved over time, with more pediatric patients with UC and CD achieving steroid-free remission at 1 and 3 years after first biologic maintenance dose.

Keyphrases

disease activity
rheumatoid arthritis
ulcerative colitis
systemic lupus erythematosus
rheumatoid arthritis patients
ankylosing spondylitis
juvenile idiopathic arthritis
nk cells
young adults